Delivery Order SPE2DB22D3004-SPE2DB25FQ82M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $1,255.38. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger procurement...
- The Defense Logistics Agency (DLA) awarded a $12,219.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 23, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award carries no set-aside designation, indicating it was competitively awarded. Performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings. This firm fixed price delivery order, issued on September 25, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,432.38 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order, with no set-aside designation, represents a routine procurement of a hormonal contraceptive product to support military healthcare needs. The order is being fulfilled from AmerisourceBergen's place of performance in...
- The Defense Logistics Agency awarded a $2,386.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with completion scheduled for September 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement through the federal medical supply chain, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,345.05 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed-price contract with an ultimate completion date of August 8, 2025. This non-set-aside delivery order was competitively awarded and represents a pharmaceutical supply fulfillment within the company's broader federal contracting portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $2,261.34 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings under a firm fixed-price contract. The award, issued on September 2, 2025, with completion targeted for September 3, 2025, represents a small-value pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $1,345.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 15, 2025. This non-set-aside award was issued on September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ82MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,002.15 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as a child delivery order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. This delivery order represents routine pharmaceutical procurement through DLA's established pharmaceutical supply chain to support military and federal healthcare systems. AmerisourceBergen's significant IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The award demonstrates the contractor's continued capability to meet federal medical supply requirements through open competition and reflects the company's role as a primary pharmaceutical vendor supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/19/25 |